+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Multiple Myeloma Epidemiology and Patient Flow - 2021

  • PDF Icon

    Report

  • February 2021
  • Region: Global
  • Fore Pharma
  • ID: 5265666
The research report, Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2021, provides Multiple Myeloma epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Multiple Myeloma patients, history of the disease at the population level (Multiple Myeloma prevalence, Multiple Myeloma incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:
  • Multiple Myeloma patient flow: Multiple Myeloma prevalence, diagnosed, and drug-treated patients
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
  • Demographics: Multiple Myeloma patients by age group, gender
  • Forecast: Multiple Myeloma epidemiology forecast to 2035

The data from this research will help executives:
  • Establish basis for Multiple Myeloma market sizing, assessing market potential, and developing drug forecast models
  • Identify Multiple Myeloma patients segments through age groups, gender, and disease sub-types
  • Develop Multiple Myeloma population-based health management frameworks
  • Evaluate Multiple Myeloma market opportunities, identify target patient population
  • Align marketing decisions with the Multiple Myeloma target population
  • Communicate leadership and health authorities about your Multiple Myeloma target patient population

Table of Contents

1. Research Methodology
2. Multiple Myeloma Patients Definition
3. US Multiple Myeloma Epidemiology and Patient Flow
4. Germany Multiple Myeloma Epidemiology and Patient Flow
5. France Multiple Myeloma Epidemiology and Patient Flow
6. Italy Multiple Myeloma Epidemiology and Patient Flow
7. Spain Multiple Myeloma Epidemiology and Patient Flow
8. UK Multiple Myeloma Epidemiology and Patient Flow
9. Europe Multiple Myeloma Epidemiology and Patient Flow
10. Japan Multiple Myeloma Epidemiology and Patient Flow
11. Global Multiple Myeloma Epidemiology and Patient Flow
12. Sources

List of Tables
1. US Multiple Myeloma Prevalence and Incidence, 2020 - 2035
2. US Multiple Myeloma Patient Sub-groups, 2020 - 2035
3. US Multiple Myeloma Patient Flow, 2020 - 2035
4. Germany Multiple Myeloma Prevalence and Incidence, 2020 - 2035
5. Germany Multiple Myeloma Patient Sub-groups, 2020 - 2035
6. Germany Multiple Myeloma Patient Flow, 2020 - 2035
7. France Multiple Myeloma Prevalence and Incidence, 2020 - 2035
8. France Multiple Myeloma Patient Sub-groups, 2020 - 2035
9. France Multiple Myeloma Patient Flow, 2020 - 2035
10. Italy Multiple Myeloma Prevalence and Incidence, 2020 - 2035
11. Italy Multiple Myeloma Patient Sub-groups, 2020 - 2035
12. Italy Multiple Myeloma Patient Flow, 2020 - 2035
13. Spain Multiple Myeloma Prevalence and Incidence, 2020 - 2035
14. Spain Multiple Myeloma Patient Sub-groups, 2020 - 2035
15. Spain Multiple Myeloma Patient Flow, 2020 - 2035
16. UK Multiple Myeloma Prevalence and Incidence, 2020 - 2035
17. UK Multiple Myeloma Patient Sub-groups, 2020 - 2035
18. UK Multiple Myeloma Patient Flow, 2020 - 2035
19. Europe Multiple Myeloma Prevalence and Incidence, 2020 - 2035
20. Europe Multiple Myeloma Patient Sub-groups, 2020 - 2035
21. Europe Multiple Myeloma Patient Flow, 2020 - 2035
22. Japan Multiple Myeloma Prevalence and Incidence, 2020 - 2035
23. Japan Multiple Myeloma Patient Sub-groups, 2020 - 2035
24. Japan Multiple Myeloma Patient Flow, 2020 - 2035
25. Global Multiple Myeloma Prevalence and Incidence, 2020 - 2035
26. Global Multiple Myeloma Patient Sub-groups, 2020 - 2035
27. Global Multiple Myeloma Patient Flow, 2020 - 2035

List of Figures
1. US Multiple Myeloma Prevalence and Incidence, 2020 - 2035
2. US Multiple Myeloma Patient by Age-Gender, 2020
3. US Multiple Myeloma Patient Flow, 2020
4. Germany Multiple Myeloma Prevalence and Incidence, 2020 - 2035
5. Germany Multiple Myeloma Patient by Age-Gender, 2020
6. Germany Multiple Myeloma Patient Flow, 2020
7. France Multiple Myeloma Prevalence and Incidence, 2020 - 2035
8. France Multiple Myeloma Patient by Age-Gender, 2020
9. France Multiple Myeloma Patient Flow, 2020
10. Italy Multiple Myeloma Prevalence and Incidence, 2020 - 2035
11. Italy Multiple Myeloma Patient by Age-Gender, 2020
12. Italy Multiple Myeloma Patient Flow, 2020
13. Spain Multiple Myeloma Prevalence and Incidence, 2020 - 2035
14. Spain Multiple Myeloma Patient by Age-Gender, 2020
15. Spain Multiple Myeloma Patient Flow, 2020
16. UK Multiple Myeloma Prevalence and Incidence, 2020 - 2035
17. UK Multiple Myeloma Patient by Age-Gender, 2020
18. UK Multiple Myeloma Patient Flow, 2020
19. Europe Multiple Myeloma Prevalence and Incidence, 2020 - 2035
20. Europe Multiple Myeloma Patient by Age-Gender, 2020
21. Europe Multiple Myeloma Patient Flow, 2020
22. Japan Multiple Myeloma Prevalence and Incidence, 2020 - 2035
23. Japan Multiple Myeloma Patient by Age-Gender, 2020
24. Japan Multiple Myeloma Patient Flow, 2020
25. Global Multiple Myeloma Prevalence and Incidence, 2020 - 2035
26. Global Multiple Myeloma Patient by Age-Gender, 2020
27. Global Multiple Myeloma Patient Flow, 2020